LOTTE BIOLOGICS’ Chief Operating Officer (COO), Hyungduk Yoo, delivered a presentation on November 21 at the Pharmaceutical and Biotech Forum, jointly organized by National Assembly Member Myung Hee Cho and the Korea Economic Daily. The event, themed "Current Status and Prospects of the Korean Pharmaceutical CMO and CDMO Market," was attended by numerous members of the National Assembly, as well as Chairman Yun Hong Noh of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) and Chairman Jeong Seok Lee of the Korea Biomedicine Industry Association.

Dr. Yoo highlighted the competitive edge of newcomers to the CMO and CDMO market and presented LOTTE BIOLOGICS' growth strategies, starting from its establishment to future business expansion. He was also enthusiastic at having the opportunity to showcase the company and expressed hope that LOTTE BIOLOGICS will continue to contribute significantly to enhancing the competitiveness of the Korean CDMO industry.

We are always delighted to share our insights at such events, and we look forward to LOTTE BIOLOGICS continuing to play a crucial role in strengthening the competitiveness of the local CDMO industry.